Diadema Partners »

Pmv Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $16k 11k 1.40

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
BML Capital Management
Tang Capital Management
Arrowpoint Asset Management
Sio Capital Management
Euclidean Capital
Vanguard Group
Acadian Asset Management
Stonepine Capital Management
BlackRock
Marshall Wace
Aldebaran Capital
Geode Capital Management
Two Sigma Advisers
Jane Street

View all funds holding Pmv Pharmaceuticals